Yesterday, JK Rowling, well-known author and women’s rights advocate, voiced her support for a recent High Court decision that upholds a ban on puberty blockers for trans children. Rowling praised the ruling, calling it a step towards “evidence-based medicine” for vulnerable youth.
The High Court’s decision came after a judge ruled that an emergency ban on prescribing puberty blockers was lawful. Mrs. Justice Lang dismissed a judicial review filed by trans activists who challenged the ban imposed in May by then Health Secretary Victoria Atkins.
The campaign group TransActual argued that Atkins had acted unlawfully by not properly consulting the public.
In her ruling, Mrs. Justice Lang stated that the health secretary had acted appropriately by making the order swiftly to protect children from potentially irresponsible prescribing practices.
The judge noted that a public consultation could have delayed the implementation of the ban and potentially allowed some to start treatment before the ban took effect.
On X, Rowling expressed her approval of the court’s decision, stating, “High court rules the UK ban on puberty blockers is lawful.
We seem, at last, to be moving back to treatment for vulnerable youth based on evidence-based medicine, as opposed to the unevidenced claims of ideological lobby groups.”
Current Health Secretary Wes Streeting also endorsed the ruling, emphasizing the need for evidence-based practices in children’s healthcare.
He reaffirmed the findings of the Cass Review, which had raised concerns about the safety and efficacy of puberty blockers for children with gender dysphoria.
Streeting stressed the importance of caution when addressing this vulnerable group.
Sir Keir Starmer echoed Streeting’s sentiments, insisting that children’s medicine should be based on solid evidence.
The Prime Minister’s spokesperson added that the government was pleased with the court’s decision.
Context of the Ban
The emergency ban on puberty blockers was introduced to address gaps in the law that allowed private clinics and European prescribers to continue administering these treatments.
This move followed the Cass Review’s findings, which criticized the existing framework for gender identity services and highlighted concerns about the lack of robust evidence supporting puberty blockers.
Responses from Advocacy Groups
Women’s rights organizations welcomed the decision. Maya Forstater from Sex Matters praised the new government’s commitment to an evidence-based approach.
On the other hand, Chay Brown of TransActual expressed disappointment, arguing that the ruling heavily relied on the discredited Cass review.
The debate over this ruling reflects ongoing discussions about the best approach to managing the healthcare needs of trans youth amidst evolving medical and societal perspectives.
TDPel Media
This article was published on TDPel Media. Thanks for reading!Share on Facebook «||» Share on Twitter «||» Share on Reddit «||» Share on LinkedIn